发布求助
文献互助 智能选刊 最新文献

Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
Tarlatamab (Imdelltra) for small cell lung cancer. 治疗小细胞肺癌的 Tarlatamab（Imdelltra）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-07-08 DOI: 10.58347/tml.2024.1706c
{"title":"Tarlatamab (Imdelltra) for small cell lung cancer.","authors":"","doi":"10.58347/tml.2024.1706c","DOIUrl":"https://doi.org/10.58347/tml.2024.1706c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141565040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison table: Some drugs for postmenopausal osteoporosis. 对照表：治疗绝经后骨质疏松症的一些药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-07-08 DOI: 10.58347/tml.2024.1706b
{"title":"Comparison table: Some drugs for postmenopausal osteoporosis.","authors":"","doi":"10.58347/tml.2024.1706b","DOIUrl":"https://doi.org/10.58347/tml.2024.1706b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141565038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction. 更正。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-06-24 DOI: 10.58347/tml.2024.1705h
{"title":"Correction.","authors":"","doi":"10.58347/tml.2024.1705h","DOIUrl":"10.58347/tml.2024.1705h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tovorafenib (Ojemda) for pediatric low-grade glioma. 治疗小儿低级别胶质瘤的托伐非尼（Ojemda）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-06-10 DOI: 10.58347/tml.2024.1704f
{"title":"Tovorafenib (Ojemda) for pediatric low-grade glioma.","authors":"","doi":"10.58347/tml.2024.1704f","DOIUrl":"https://doi.org/10.58347/tml.2024.1704f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beqvez - another gene therapy for hemophilia B. Beqvez--另一种治疗 B 型血友病的基因疗法。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-06-10 DOI: 10.58347/tml.2024.1704d
{"title":"Beqvez - another gene therapy for hemophilia B.","authors":"","doi":"10.58347/tml.2024.1704d","DOIUrl":"https://doi.org/10.58347/tml.2024.1704d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Budesonide oral suspension (Eohilia) for eosinophilic esophagitis. 治疗嗜酸性粒细胞食管炎的布地奈德口服混悬液（Eohilia）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-06-10 DOI: 10.58347/tml.2024.1704c
{"title":"Budesonide oral suspension (Eohilia) for eosinophilic esophagitis.","authors":"","doi":"10.58347/tml.2024.1704c","DOIUrl":"https://doi.org/10.58347/tml.2024.1704c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs for head lice. 治疗头虱的药物
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-06-10 DOI: 10.58347/tml.2024.1704a
{"title":"Drugs for head lice.","authors":"","doi":"10.58347/tml.2024.1704a","DOIUrl":"10.58347/tml.2024.1704a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addendum: Relyvrio withdrawn. 增编：撤回 Relyvrio。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-06-10 DOI: 10.58347/tml.2024.1704e
{"title":"Addendum: Relyvrio withdrawn.","authors":"","doi":"10.58347/tml.2024.1704e","DOIUrl":"https://doi.org/10.58347/tml.2024.1704e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aprocitentan (Tryvio) for hypertension. 治疗高血压的 Aprocitentan（Tryvio）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-06-10 DOI: 10.58347/tml.2024.1704b
{"title":"Aprocitentan (Tryvio) for hypertension.","authors":"","doi":"10.58347/tml.2024.1704b","DOIUrl":"https://doi.org/10.58347/tml.2024.1704b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tislelizumab (Tevimbra) for esophageal cancer. 治疗食道癌的 Tislelizumab（Tevimbra）。
IF 1.9 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-05-13 DOI: 10.58347/tml.2024.1702h
{"title":"Tislelizumab (Tevimbra) for esophageal cancer.","authors":"","doi":"10.58347/tml.2024.1702h","DOIUrl":"https://doi.org/10.58347/tml.2024.1702h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141077391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信